Swiss National Bank
IRON icon

Swiss National Bank’s Disc Medicine IRON Stock Holding History

Swiss National Bank’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.64M Buy
49,800
+1,800
+4% +$124K ﹤0.01% 1625
2026
Q1 		$3.07M Hold
48,000
– – ﹤0.01% 1628
2025
Q4 		$3.81M Buy
48,000
+4,400
+10% +$372K ﹤0.01% 1504
2025
Q3 		$2.88M Buy
43,600
+700
+2% +$41.6K ﹤0.01% 1655
2025
Q2 		$2.27M Buy
42,900
+7,000
+19% +$329K ﹤0.01% 1728
2025
Q1 		$1.78M Buy
35,900
+3,700
+11% +$206K ﹤0.01% 1839
2024
Q4 		$2.04M Sell
32,200
-2,600
-7% -$150K ﹤0.01% 1844
2024
Q3 		$1.71M Buy
34,800
+2,800
+9% +$131K ﹤0.01% 1952
2024
Q2 		$1.44M Buy
32,000
+8,200
+34% +$279K ﹤0.01% 1982
2024
Q1 		$1.48M Buy
23,800
+8,000
+51% +$519K ﹤0.01% 2003
2023
Q4 		$913K Sell
15,800
-1,600
-9% -$81.9K ﹤0.01% 2291
2023
Q3 		$817K Buy
+17,400
New +$870K ﹤0.01% 2352

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Swiss National Bank's IRON Position: Q2 2026 in Review

Swiss National Bank increased its Disc Medicine (IRON) stake by 3.8% in Q2 2026, buying an estimated $124K and bringing the position to 49,800 shares worth $3.64M. The position accounts for ﹤0.01% of the portfolio, ranked #1625.

Swiss National Bank first reported a position in IRON in Q3 2023 and has held it in 12 quarters since. The position peaked at $3.81M in Q4 2025. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Swiss National Bank held 49,800 shares of Disc Medicine worth $3.64M as of Q2 2026.
  • Swiss National Bank bought 1,800 Disc Medicine shares in Q2 2026, an estimated $124K.
  • Disc Medicine made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #1625 holding.
  • Swiss National Bank first reported a position in Disc Medicine in Q3 2023 and has held it in 12 quarters since.
  • Swiss National Bank's Disc Medicine position peaked at $3.81M in Q4 2025.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.